397 related articles for article (PubMed ID: 25601314)
1. Antimicrobial efficacy of granulysin-derived synthetic peptides in acne vulgaris.
Lim HS; Chun SM; Soung MG; Kim J; Kim SJ
Int J Dermatol; 2015 Jul; 54(7):853-62. PubMed ID: 25601314
[TBL] [Abstract][Full Text] [Related]
2. Granulysin-derived peptides demonstrate antimicrobial and anti-inflammatory effects against Propionibacterium acnes.
McInturff JE; Wang SJ; Machleidt T; Lin TR; Oren A; Hertz CJ; Krutzik SR; Hart S; Zeh K; Anderson DH; Gallo RL; Modlin RL; Kim J
J Invest Dermatol; 2005 Aug; 125(2):256-63. PubMed ID: 16098035
[TBL] [Abstract][Full Text] [Related]
3. Peptides with antimicrobial and anti-inflammatory activities that have therapeutic potential for treatment of acne vulgaris.
Popovic S; Urbán E; Lukic M; Conlon JM
Peptides; 2012 Apr; 34(2):275-82. PubMed ID: 22374306
[TBL] [Abstract][Full Text] [Related]
4. SIG1273: a new cosmetic functional ingredient to reduce blemishes and Propionibacterium acnes in acne prone skin.
Fernandéz JR; Rouzard K; Voronkov M; Feng X; Stock JB; Stock M; Gordon JS; Shroot B; Christensen MS; Pérez E
J Cosmet Dermatol; 2012 Dec; 11(4):272-8. PubMed ID: 23174050
[TBL] [Abstract][Full Text] [Related]
5. What is the role of antimicrobial peptides (AMP) in acne vulgaris?
Harder J; Tsuruta D; Murakami M; Kurokawa I
Exp Dermatol; 2013 Jun; 22(6):386-91. PubMed ID: 23711061
[TBL] [Abstract][Full Text] [Related]
6. Suppression of Propionibacterium acnes Infection and the Associated Inflammatory Response by the Antimicrobial Peptide P5 in Mice.
Ryu S; Han HM; Song PI; Armstrong CA; Park Y
PLoS One; 2015; 10(7):e0132619. PubMed ID: 26197393
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of the antimicrobial peptide BLP-7 against Propionibacterium acnes and its anti-inflammatory effect on acne vulgaris.
Wu Y; Qiang Y; Cao K; Zhang W; Zhang G
Toxicon; 2020 Sep; 184():109-115. PubMed ID: 32540219
[TBL] [Abstract][Full Text] [Related]
8. A Polycation Antimicrobial Peptide Mimic without Resistance Buildup against Propionibacterium Acnes.
Nair SS; Zolotarskaya OY; Beckwith MJ; Ohman DE; Wynne KJ
Macromol Biosci; 2017 Sep; 17(9):. PubMed ID: 28605136
[TBL] [Abstract][Full Text] [Related]
9. The antimicrobial effect of CEN1HC-Br against Propionibacterium acnes and its therapeutic and anti-inflammatory effects on acne vulgaris.
Han R; Blencke HM; Cheng H; Li C
Peptides; 2018 Jan; 99():36-43. PubMed ID: 29108811
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic resistance in the topical treatment of acne vulgaris.
Leyden JJ
Cutis; 2004 Jun; 73(6 Suppl):6-10. PubMed ID: 15228128
[TBL] [Abstract][Full Text] [Related]
11. A Multifactorial Comparison of Ternary Combinations of Essential Oils in Topical Preparations to Current Antibiotic Prescription Therapies for the Control of Acne Vulgaris-Associated Bacteria.
Owen L; Grootveld M; Arroo R; Ruiz-Rodado V; Price P; Laird K
Phytother Res; 2017 Mar; 31(3):410-417. PubMed ID: 28124400
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility of Propionibacterium acnes isolates from acne patients in Colombia.
Mendoza N; Hernandez PO; Tyring SK; Haitz KA; Motta A
Int J Dermatol; 2013 Jun; 52(6):688-92. PubMed ID: 23451873
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory and anti-inflammatory effects of the Helicobacter pylori-derived antimicrobial peptide HPA3NT3 against Propionibacterium acnes in the skin.
Ryu S; Park Y; Kim B; Cho SM; Lee J; Lee HH; Gurley C; Song K; Johnson A; Armstrong CA; Song PI
Br J Dermatol; 2014 Dec; 171(6):1358-67. PubMed ID: 25313444
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory activity of cationic peptides: application to the treatment of acne vulgaris.
Marta Guarna M; Coulson R; Rubinchik E
FEMS Microbiol Lett; 2006 Apr; 257(1):1-6. PubMed ID: 16553825
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of enterocins from Enterococcus faecalis SL-5 against Propionibacterium acnes, the causative agent in acne vulgaris, and its therapeutic effect.
Kang BS; Seo JG; Lee GS; Kim JH; Kim SY; Han YW; Kang H; Kim HO; Rhee JH; Chung MJ; Park YM
J Microbiol; 2009 Feb; 47(1):101-9. PubMed ID: 19229497
[TBL] [Abstract][Full Text] [Related]
16. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
Dreno B; Foulc P; Reynaud A; Moyse D; Habert H; Richet H
Eur J Dermatol; 2005; 15(3):152-5. PubMed ID: 15908296
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris.
Kurokawa I; Nishijima S; Kawabata S
Eur J Dermatol; 1999; 9(1):25-8. PubMed ID: 9920982
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory and anti-inflammatory effects of two antimicrobial peptides moronecidin and temporin-1Dra against Propionibacterium acnes in vitro and in vivo.
Wu Y; Zhang G; Zhou M
J Pept Sci; 2020 Jul; 26(7):e3255. PubMed ID: 32567152
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of Propionibacterium acnes isolated from acne patients: comparative study of antimicrobial agents.
Nishijima S; Kurokawa I; Kawabata S
J Int Med Res; 1996; 24(6):473-7. PubMed ID: 8959531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
